✦ LIBER ✦

Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation

✍ Scribed by Timothy D. Jones; John N. Eble; Mingsheng Wang; Gregory T. MacLennan; Shashi Jain; Liang Cheng

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 1007 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21288

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histologic evaluation of metastases in r

Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy

✍ Brian Shuch; Jonathan Said; Jeffrey C. LaRochelle; Ying Zhou; Gang Li; Tobias Kl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Osteopontin expression correlates with p

Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma

✍ Koviljka Matusan; Gordana Dordevic; Darko Stipic; Vladimir Mozetic; Ksenija Luci 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

## Abstract ## Background and Objectives Osteopontin (OPN) is a phosphorylated glycoprotein with diverse functions including tumorigenesis and tumor cell metastasis. Recently, it has been detected in a growing number of human tumors, and assessed as a potential prognostic marker. The aim of this s

Correlation of CD44S expression in renal

Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence

✍ Michael Z. Gilcrease; Manuel Guzman-Paz; Gloria Niehans; David Cherwitz; James B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## BACKGROUND. Recent reports have shown altered expression of CD44 in renal cell carcinomas. However, to the authors' knowledge there are no data correlating CD44 expression in renal cell carcinomas with subsequent tumor progression or recurrence, nor is there information about the presence of pa

Nuclear DNA content-derived parameters c

Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas

✍ Stefano Pepe; Angela Ruggiero; Maria D'Acquisto; Michelino De Laurentiis; Sabino 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 895 KB

Low frequency of HLA haplotype loss asso

Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas

✍ Isabel Maleno; Miguel Angel Lopez Nevot; Barbara Seliger; Federico Garrido 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 94 KB 👁 1 views

## Abstract HLA class I loss or downregulation is a widespread mechanism used by tumor cells to avoid tumor recognition by cytotoxic T lymphocytes favoring tumor immune escape. Multiple molecular mechanisms are responsible for these altered HLA class I tumor phenotypes. It has been described in dif

Somatic von Hippel–Lindau disease gene m

Somatic von Hippel–Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney

✍ Minoru Yoshida; Masahiro Yao; Isao Ishikawa; Takeshi Kishida; Yoji Nagashima; Ke 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 1 views

## Abstract It has been documented that renal cell carcinomas (RCCs) occur frequently in patients treated with long‐term dialysis, especially in cases of end‐stage renal disease (ESRD)/acquired cystic disease of the kidney (ACDK). To address the molecular pathogenesis of ESRD/ACDK‐associated RCCs,